Journal article icon

Journal article : Comment

Extending treatment eligibility for chronic hepatitis B virus infection

Abstract:
Progress towards hepatitis B virus (HBV) elimination targets remains slow, despite efforts to support enhanced prevention, diagnosis and treatment. On the basis of insights from interventions against HIV, we argue for the wider use of antiviral therapy for HBV, highlighting the potential public health benefits in preventing liver disease and reducing transmission.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41575-020-00398-x

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
NDM Experimental Medicine
Oxford college:
Harris Manchester College
Role:
Author
ORCID:
0000-0002-4036-4269
Publisher:
Springer Nature Publisher's website
Journal:
Nature Reviews Gastroenterology and Hepatology Journal website
Volume:
18
Issue:
3
Pages:
146–147
Publication date:
2020-12-15
Acceptance date:
2020-12-08
DOI:
EISSN:
1759-5053
ISSN:
1759-5045
Language:
English
Keywords:
Subtype:
Comment
Pubs id:
1148333
Local pid:
pubs:1148333
Deposit date:
2020-12-09

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP